4512 — Wakamoto Pharmaceutical Share News
0.000.00%
Last trade - 00:00Table: Wakamoto Pharm -2022/23 parent results
Table: Wakamoto Pharm -2022/23 parent forecast
Table: Wakamoto Pharm -2022/23 div forecast
Table: Wakamoto Pharm - 9-MTH parent results
Table: Wakamoto Pharm - 6-MTH parent results
Table: Wakamoto Pharm - Q1 parent results
Table: Wakamoto Pharm -2021/22 parent results
Table: Wakamoto Pharm -2021/22 parent forecast
Table: Wakamoto Pharm -2021/22 div forecast
Table: Wakamoto Pharm - 9-MTH parent results
Table: Wakamoto Pharm - 9-MTH parent results
Table: Wakamoto Pharm - 6-MTH parent results
Brief: Harrow Health Acquires Eye Surgery Trial Drug From Wakamoto Pharmaceutical
Table: Wakamoto Pharm -2021/22 parent forecast
Table: Wakamoto Pharm - Q1 parent results
Table: Wakamoto Pharm -2020/21 parent results
Table: Wakamoto Pharm - 9-MTH parent results
Table: Wakamoto Pharm -2020/21 div forecast
Table: Wakamoto Pharm - 6-MTH parent results